Oral Contraception and the Risk of Thromboembolism: What Does it Mean to Clinicians and Their Patients?

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.13, 2002-01, pp. : 893-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Package Design Matter for Patients?: The Association Between Package Design and Patients' Drug Knowledge

By Wilke Thomas

Pharmaceutical Medicine, Vol. 25, Iss. 5, 2011-10 ,pp. : 307-317

Adis International

Access to resources Recommend Favorite

Match SSRIs to patients?

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Is Tamiflu safe for paediatric patients?

Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

High-dose eptifibatide cost saving in low-risk PCI patients?

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?

By Lee Ming-Han H. Graham Garry G. Williams Kenneth M. Day Richard O.

Drug Safety, Vol. 31, Iss. 8, 2008-01 ,pp. : 643-665

Adis International

Access to resources Recommend Favorite